267 related articles for article (PubMed ID: 11451847)
1. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
Johnson M; Rennard S
Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
[TBL] [Abstract][Full Text] [Related]
2. Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?
Tennant RC; Erin EM; Barnes PJ; Hansel TT
Curr Opin Pharmacol; 2003 Jun; 3(3):270-6. PubMed ID: 12810191
[TBL] [Abstract][Full Text] [Related]
3. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease.
Appleton S; Poole P; Smith B; Veale A; Lasserson TJ; Chan MM
Cochrane Database Syst Rev; 2006 Jul; (3):CD001104. PubMed ID: 16855959
[TBL] [Abstract][Full Text] [Related]
4. Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease.
Cazzola M; Santangelo G; Piccolo A; Salzillo A; Matera MG; D'Amato G; Rossi F
Pulm Pharmacol; 1994 Apr; 7(2):103-7. PubMed ID: 7915921
[TBL] [Abstract][Full Text] [Related]
5. Long-acting beta 2-agonists.
Tattersfield AE
Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
[No Abstract] [Full Text] [Related]
6. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
Noppen M; Vincken W
Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
[No Abstract] [Full Text] [Related]
8. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
Celik G; Kayacan O; Beder S; Durmaz G
Respiration; 1999; 66(5):434-9. PubMed ID: 10516540
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists for chronic obstructive pulmonary disease.
Appleton S; Smith B; Veale A; Bara A
Cochrane Database Syst Rev; 2000; (2):CD001104. PubMed ID: 10796594
[TBL] [Abstract][Full Text] [Related]
10. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
Grove A; Lipworth BJ
Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
[TBL] [Abstract][Full Text] [Related]
11. Long-acting beta agonists in asthma therapy.
Rissmiller RW; Larj MJ; Peters SP
Curr Allergy Asthma Rep; 2004 Mar; 4(2):91-2. PubMed ID: 14769255
[No Abstract] [Full Text] [Related]
12. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological similarities and differences between beta2-agonists.
Lötvall J
Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
[TBL] [Abstract][Full Text] [Related]
14. The role of long-acting bronchodilators in the management of stable COPD.
Tashkin DP; Cooper CB
Chest; 2004 Jan; 125(1):249-59. PubMed ID: 14718448
[TBL] [Abstract][Full Text] [Related]
15. Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.
Decramer M; Ferguson G
COPD; 2006 Aug; 3(3):163-71. PubMed ID: 17240618
[TBL] [Abstract][Full Text] [Related]
16. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease.
Rennard SI; Anderson W; ZuWallack R; Broughton J; Bailey W; Friedman M; Wisniewski M; Rickard K
Am J Respir Crit Care Med; 2001 Apr; 163(5):1087-92. PubMed ID: 11316640
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta(2)-agonists in childhood asthma: Don't change a winning team (yet).
Verberne AA; de Jongste JC
Pediatr Pulmonol; 2000 Mar; 29(3):169-71. PubMed ID: 10686035
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of long-acting beta-receptor agonists.
Tattersfield AE
Life Sci; 1993; 52(26):2161-9. PubMed ID: 8099697
[TBL] [Abstract][Full Text] [Related]
19. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
Matthys H
Respiration; 2001; 68(4):432-7. PubMed ID: 11464097
[TBL] [Abstract][Full Text] [Related]
20. Airway-stabilizing effect of long-acting beta2-agonists as add-on therapy to inhaled corticosteroids.
Currie GP; Jackson CM; Ogston SA; Lipworth BJ
QJM; 2003 Jun; 96(6):435-40. PubMed ID: 12788962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
